Trademark: 88603003
Status Date
Monday, October 11, 2021
Filing Date
Tuesday, September 3, 2019
Published for Opposition
Tuesday, January 14, 2020
Abandoned Date
Monday, October 11, 2021
NP2 -
Owner At Publication
5 Pharmaceutical preparations for the treatment of cancer and infectious diseases
Oct 12, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 11, 2021
Abandonment - No Use Statement Filed
Feb 17, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 15, 2021
Extension 2 Granted
Feb 15, 2021
Extension 2 Filed
Feb 15, 2021
Teas Extension Received
Sep 10, 2020
Notice Of Approval Of Extension Request E-Mailed
Sep 8, 2020
Extension 1 Granted
Sep 8, 2020
Extension 1 Filed
Sep 8, 2020
Teas Extension Received
Mar 10, 2020
Noa E-Mailed - Sou Required From Applicant
Jan 14, 2020
Official Gazette Publication Confirmation E-Mailed
Jan 14, 2020
Published For Opposition
Dec 25, 2019
Notification Of Notice Of Publication E-Mailed
Dec 11, 2019
Assigned To Lie
Dec 6, 2019
Approved For Pub - Principal Register
Dec 6, 2019
Examiner's Amendment Entered
Dec 6, 2019
Notification Of Examiners Amendment E-Mailed
Dec 6, 2019
Examiners Amendment E-Mailed
Dec 6, 2019
Examiners Amendment -Written
Dec 5, 2019
Assigned To Examiner
Sep 13, 2019
New Application Office Supplied Data Entered In Tram
Sep 6, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
